Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Rhode Island's Opioid Trial Against Teva Begins Today: Reuters

  • The first trial in Rhode Island state court against Teva Pharmaceutical Industries Ltd's (NYSE:TEVA) alleged responsibility for the opioid crisis begins jury selection Monday.
  • The case begins over whether Teva contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades.
  • Rhode Island says Teva created a "public nuisance" by downplaying the risks of opioid addiction and promoting the off-label use of fentanyl-based opioids that were approved only for certain types of cancer pain.
  • According to a Teva court filing, Rhode Island is seeking $5.9 billion from the companies.
  • Also See: Teva, Texas Enter $225M Opioid Settlement Agreement.
  • Teva subsidiaries Actavis Pharma and Cephalon Inc are also defendants in Rhode Island Superior Court in Providence.
  • The companies have denied the allegations, saying they sold legal and approved drugs for pain treatment.
  • In court filings by Teva, it calls Rhode Island's lawsuit an improper attempt to blame a wide-ranging public health crisis on "a small subset of opioid manufacturers" that make "niche" medicines like Actiq and Fentora. 
  • Teva also sells generic opioids such as oxycodone.
  • Price Action: TEVA shares are down 2.61% at $7.29 during the market session on the last check Monday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.